- Home
- SN vs PCVX Comparison
SN vs PCVX Comparison
Compare SN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SN
- PCVX
- Stock Information
- Founded
- SN 1993
- PCVX 2013
- Country
- SN United States
- PCVX United States
- Employees
- SN N/A
- PCVX N/A
- Industry
- SN
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- SN
- PCVX Health Care
- Exchange
- SN Nasdaq
- PCVX Nasdaq
- Market Cap
- SN 13.8B
- PCVX 11.5B
- IPO Year
- SN N/A
- PCVX 2020
- Fundamental
- Price
- SN $102.93
- PCVX $79.74
- Analyst Decision
- SN Strong Buy
- PCVX Strong Buy
- Analyst Count
- SN 9
- PCVX 8
- Target Price
- SN $122.50
- PCVX $127.71
- AVG Volume (30 Days)
- SN 1.3M
- PCVX 881.2K
- Earning Date
- SN 02-13-2025
- PCVX 02-25-2025
- Dividend Yield
- SN N/A
- PCVX N/A
- EPS Growth
- SN 159.17
- PCVX N/A
- EPS
- SN 3.11
- PCVX N/A
- Revenue
- SN $5,528,639,000.00
- PCVX N/A
- Revenue This Year
- SN $16.32
- PCVX N/A
- Revenue Next Year
- SN $11.10
- PCVX N/A
- P/E Ratio
- SN $33.10
- PCVX N/A
- Revenue Growth
- SN 29.97
- PCVX N/A
- 52 Week Low
- SN $52.17
- PCVX $58.10
- 52 Week High
- SN $123.00
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- SN 39.30
- PCVX 36.96
- Support Level
- SN $107.46
- PCVX $82.03
- Resistance Level
- SN $112.40
- PCVX $84.10
- Average True Range (ATR)
- SN 5.64
- PCVX 3.12
- MACD
- SN -1.01
- PCVX -0.70
- Stochastic Oscillator
- SN 2.10
- PCVX 1.88
About SN SharkNinja Inc.
SharkNinja Inc is a product design and technology company that creates 5-star-rated lifestyle solutions through inventive products for consumers around the world. Its product categories include Cleaning, Cooking, Food Preparation, Home Environment and Beauty products. It sells vacuum cleaners, cooking pots, fryers, hair dryers, etc. The SharkNinja Group is expected to carry on the design, production, marketing and distribution of the Shark and Ninja brands of small household appliances in North America, Europe and other selected international markets (excluding the Asia Pacific Region and Greater China). Currently, the majority of the revenue is derived from the U.S. market.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.